T2-associated asthma is characterized by the release of interleukins IL-13 and IL-5, promoting eosinophilic infiltration, pro-inflammatory loops, epithelial cell proliferation, goblet-cell metaplasia, and ciliary beating alterations (1). Here, IL5 is linked to asthma.